Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 349368, 10 pages
http://dx.doi.org/10.1155/2011/349368
Review Article

Thymic Self-Antigen Expression for the Design of a Negative/Tolerogenic Self-Vaccine against Type 1 Diabetes

1Department of Immunology, Faculty of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia
2University of Liege Center of Immunology, Institute of Pathology CHU-B23, B-4000 Liege-Sart Tilman, Belgium

Received 11 January 2011; Accepted 8 March 2011

Academic Editor: Abdelaziz Amrani

Copyright © 2011 Aziz Alami Chentoufi and Vincent Geenen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. P. Di Lorenzo, M. Peakman, and B. O. Roep, “Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes,” Clinical and Experimental Immunology, vol. 148, no. 1, pp. 1–16, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. T. K. Starr, S. C. Jameson, and K. A. Hogquist, “Positive and negative selection of T cells,” Annual Review of Immunology, vol. 21, pp. 139–176, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. L. S. K. Walker and A. K. Abbas, “The enemy within: keeping self-reactive T cells at bay in the periphery,” Nature Reviews Immunology, vol. 2, no. 1, pp. 11–19, 2002. View at Google Scholar · View at Scopus
  4. P. S. Ohashi, “Negative selection and autoimmunity,” Current Opinion in Immunology, vol. 15, no. 6, pp. 668–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Chentoufi, M. Palumbo, and C. Polychronakos, “Proinsulin expression by Hassall's corpuscles in the mouse thymus,” Diabetes, vol. 53, no. 2, pp. 354–359, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. A. Chentoufi and C. Polychronakos, “Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes,” Diabetes, vol. 51, no. 5, pp. 1383–1390, 2002. View at Google Scholar · View at Scopus
  7. B. Kyewski and L. Klein, “A central role for central tolerance,” Annual Review of Immunology, vol. 24, pp. 571–606, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. Pitkänen and P. Peterson, “Autoimmune regulator: from loss of function to autoimmunity,” Genes and Immunity, vol. 4, no. 1, pp. 12–21, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. S. Anderson, E. S. Venanzi, L. Klein et al., “Projection of an immunological self shadow within the thymus by the aire protein,” Science, vol. 298, no. 5597, pp. 1395–1401, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. J. Cabarrocas, C. Cassan, F. Magnusson et al., “Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 22, pp. 8453–8458, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. K. Aschenbrenner, L. M. D'Cruz, E. H. Vollmann et al., “Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire medullary thymic epithelial cells,” Nature Immunology, vol. 8, no. 4, pp. 351–358, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. G. F. Bottazzo, A. Florin Christensen, and D. Doniach, “Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies,” The Lancet, vol. 2, no. 7892, pp. 1279–1283, 1974. View at Google Scholar · View at Scopus
  13. J. M. Wenzlau, K. Juhl, L. Yu et al., “The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 43, pp. 17040–17045, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. B. D. Stadinski, T. Delong, N. Reisdorph et al., “Chromogranin A is an autoantigen in type 1 diabetes,” Nature Immunology, vol. 11, no. 3, pp. 225–231, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. M. Nakayama, N. Abiru, H. Moriyama et al., “Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice,” Nature, vol. 435, no. 7039, pp. 220–223, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. S. C. Kent, Y. Chen, L. Bregoli et al., “Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope,” Nature, vol. 435, no. 7039, pp. 224–228, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. E. A. M. Gale and P. J. Bingley, “Autoimmune type 1 diabetes,” in Immunoendocrinology in Health and Disease, V. Geenen and G. P. Chrousos, Eds., pp. 417–438, Marcel Dekker, New York, NY, USA, 2004. View at Google Scholar
  18. A. L. Notkins and A. Lernmark, “Autoimmune type 1 diabetes: resolved and unresolved issues,” Journal of Clinical Investigation, vol. 108, no. 9, pp. 1247–1252, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Martin, D. Wolf-Eichbaum, G. Duinkerken et al., “Development of type 1 diabetes despite severe hereditary B-cell deficiency,” The New England Journal of Medicine, vol. 345, no. 14, pp. 1036–1040, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. B. O. Roep, “The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure,” Diabetologia, vol. 46, no. 3, pp. 305–321, 2003. View at Google Scholar · View at Scopus
  21. S. Arif, T. I. Tree, T. P. Astill et al., “Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health,” Journal of Clinical Investigation, vol. 113, no. 3, pp. 451–463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. K. C. Herold, B. Brooks-Worrell, J. Palmer et al., “Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes,” Diabetes, vol. 58, no. 11, pp. 2588–2595, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. V. Geenen and G. Kroemer, “Multiple ways to cellular immune tolerance,” Immunology Today, vol. 14, no. 12, pp. 573–575, 1993. View at Google Scholar · View at Scopus
  24. H. Martens, B. Goxe, and V. Geenen, “The thymic repertoire of neuroendocrine self-antigens: physiological implications in T-cell life and death,” Immunology Today, vol. 17, no. 7, pp. 312–317, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. M. L. Dion, R. Bordi, J. Zeidan et al., “Slow disease progression and robust therapy-mediated CD4+ T-cell recovery are associated with efficient thymopoiesis during HIV-1 infection,” Blood, vol. 109, no. 7, pp. 2912–2920, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. E. Castermans, F. Baron, E. Willems et al., “Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning,” Haematologica, vol. 93, no. 2, pp. 240–247, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. G. Morrhaye, H. Kermani, J. J. Legros et al., “Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients,” PLoS ONE, vol. 4, no. 5, Article ID e5668, 2009. View at Publisher · View at Google Scholar · View at PubMed
  28. R. L. Boyd, C. L. Tucek, D. I. Godfrey et al., “The thymic microenvironment,” Immunology Today, vol. 14, no. 9, pp. 445–459, 1993. View at Google Scholar · View at Scopus
  29. D. D. Patel, L. P. Whichard, G. Radcliff, S. M. Denning, and B. F. Haynes, “Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes,” Journal of Clinical Immunology, vol. 15, no. 2, pp. 80–92, 1995. View at Google Scholar · View at Scopus
  30. L. Klein, M. Hinterberger, G. Wirnsberger, and B. Kyewski, “Antigen presentation in the thymus for positive selection and central tolerance induction,” Nature Reviews Immunology, vol. 9, no. 12, pp. 833–844, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. H. Von Boehmer, “Central tolerance: essential for preventing autoimmune disease?” European Journal of Immunology, vol. 39, no. 9, pp. 2313–2316, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. P. G. Ashton-Rickardt, A. Bandeira, J. R. Delaney et al., “Evidence for a differential avidity model of T cell selection in the thymus,” Cell, vol. 76, no. 4, pp. 651–663, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Vanneste, A. Ntodou Thome, E. Vandersmissen et al., “Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules,” Journal of Neuroimmunology, vol. 76, no. 1-2, pp. 161–166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Geenen, F. Brilot, I. Hansenne, and H. Martens, “Thymus and T cells,” in Encyclopedia of Neuroscience on CD-ROM, G. Adelman and B. H. Smith, Eds., Elsevier, New York, NY, USA, 3rd edition, 2003. View at Google Scholar
  35. J. Derbinski, J. Gäbler, B. Brors et al., “Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 33–45, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. I. Hansenne, C. Renard-Charlet, R. Greimers, and V. Geenen, “Dendritic cell differentiation and immune tolerance to insulin-related peptides in Igf2-deficient mice,” Journal of Immunology, vol. 176, no. 8, pp. 4651–4657, 2006. View at Google Scholar · View at Scopus
  37. F. M. Burnet, “A reassessment of the forbidden clone hypothesis of autoimmune disease,” The Australian journal of experimental biology and medical science, vol. 50, no. 1, pp. 1–9, 1972. View at Google Scholar · View at Scopus
  38. F. R. Robert, H. Martens, N. Cormann, A. Benhida, J. Schoenen, and V. Geenen, “The recognition of hypothalamo-neurohypophysial functions by developing T cells,” Developmental immunology, vol. 2, no. 2, pp. 131–140, 1992. View at Google Scholar · View at Scopus
  39. H. Kishimoto and J. Sprent, “A defect in central tolerance in NOD mice,” Nature Immunology, vol. 2, no. 11, pp. 1025–1031, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. Zucchelli, P. Holler, T. Yamagata, M. Roy, C. Benoist, and D. Mathis, “Defective central tolerance induction in NOD mice: genomics and genetics,” Immunity, vol. 22, no. 3, pp. 385–396, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. O. Kecha-Kamoun, I. Achour, H. Martens et al., “Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 17, no. 2, pp. 146–152, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. V. Geenen and P. J. Lefèbvre, “The intrathymic expression of insulin-related genes: implications for pathophysiology and prevention of Type 1 diabetes,” Diabetes/Metabolism Reviews, vol. 14, no. 1, pp. 95–103, 1998. View at Google Scholar · View at Scopus
  43. K. Thébault-Baumont, D. Dubois-Laforgue, P. Krief et al., “Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice,” Journal of Clinical Investigation, vol. 111, no. 6, pp. 851–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Moriyama, N. Abiru, J. Paronen et al., “Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 18, pp. 10376–10381, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. P. Vafiadis, S. T. Bennett, J. A. Todd et al., “Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus,” Nature Genetics, vol. 15, no. 3, pp. 289–292, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. A. Pugliese, M. Zeller, A. Fernandez et al., “The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes,” Nature Genetics, vol. 15, no. 3, pp. 293–297, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. Y. Fan, W. A. Rudert, M. Grupillo, J. He, G. Sisino, and M. Trucco, “Thymus-specific deletion of insulin induces autoimmune diabetes,” EMBO Journal, vol. 28, no. 18, pp. 2812–2824, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. K. Nagamine, P. Peterson, H. S. Scott et al., “Positional cloning of the APECED gene,” Nature Genetics, vol. 17, no. 4, pp. 393–398, 1997. View at Google Scholar · View at Scopus
  49. Finnish-German APECED Consortium, “An autoimmune disease, APECED, caused bymutations in a novel gene featuring two PHD-type zinc-finger domains,” Nature Genetics, vol. 17, pp. 399–403, 1997. View at Google Scholar
  50. M. Heino, P. Peterson, N. Sillanpää et al., “RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse,” European Journal of Immunology, vol. 30, no. 7, pp. 1884–1893, 2000. View at Google Scholar · View at Scopus
  51. C. Ramsey, O. Winqvist, L. Puhakka et al., “Aire deficient mice develop multiple features of APECED phenotype and show altered immune response,” Human Molecular Genetics, vol. 11, no. 4, pp. 397–409, 2002. View at Google Scholar · View at Scopus
  52. F. X. Hubert, S. A. Kinkel, P. E. Crewther et al., “Aire-deficient C57BL/6 mice mimicking the common human 13-base pair deletion mutation present with only a mild autoimmune phenotype,” Journal of Immunology, vol. 182, no. 6, pp. 3902–3918, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. J. Derbinski, J. Gäbler, B. Brors et al., “Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels,” Journal of Experimental Medicine, vol. 202, no. 1, pp. 33–45, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. J. M. Gardner, J. J. DeVoss, R. S. Friedman et al., “Deletional tolerance mediated by extrathymic aire-expressing cells,” Science, vol. 321, no. 5890, pp. 843–847, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. D. Mathis and C. Benoist, “Aire,” Annual Review of Immunology, vol. 27, pp. 287–312, 2009. View at Publisher · View at Google Scholar · View at PubMed
  56. P. Peterson, T. Org, and A. Rebane, “Transcriptional regulation by AIRE: molecular mechanisms of central tolerance,” Nature Reviews Immunology, vol. 8, no. 12, pp. 948–957, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  57. T. Org, F. Chignola, C. Hetényi et al., “The autoimmune regulator PHD finger binds to non-methylated histone H3K4 to activate gene expression,” EMBO Reports, vol. 9, no. 4, pp. 370–376, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. A. S. Koh, A. J. Kuo, Y. P. Sang et al., “Aire employs a histone-binding module to mediate immunological tolerance, linking chromatin regulation with organ-specific autoimmunity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 41, pp. 15878–15883, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  59. M. Matsumoto, “Contrasting models for the roles of Aire in the differentiation program of epithelial cells in the thymic medulla,” European Journal of Immunology, vol. 41, no. 1, pp. 12–17, 2011. View at Publisher · View at Google Scholar · View at PubMed
  60. F. Brilot, W. Chehadeh, C. Charlet-Renard, H. Martens, V. Geenen, and D. Hober, “Persistent infection of human thymic epithelial cells by coxsackievirus B4,” Journal of Virology, vol. 76, no. 10, pp. 5260–5265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Brilot, V. Geenen, D. Hober, and C. A. Stoddart, “Coxsackievirus B4 infection of human fetal thymus cells,” Journal of Virology, vol. 78, no. 18, pp. 9854–9861, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  62. H. Jaïdane, J. Gharbi, P. E. Lobert et al., “Prolonged viral RNA detection in blood and lymphoid tissues from Coxsackievirus B4 E2 orally-inoculated Swiss mice,” Microbiology and Immunology, vol. 50, no. 12, pp. 971–974, 2006. View at Google Scholar · View at Scopus
  63. P. A. Taylor, R. J. Noelle, and B. R. Blazar, “CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade,” Journal of Experimental Medicine, vol. 193, no. 11, pp. 1311–1317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Singh, S. Read, C. Asseman et al., “Control of intestinal inflammation by regulatory T cells,” Immunological Reviews, vol. 182, pp. 190–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. Y. Belkaid, R. B. Blank, and I. Suffia, “Natural regulatory T cells and parasites: a common quest for host homeostasis,” Immunological Reviews, vol. 212, pp. 287–300, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. I. P. Lewkowich, N. S. Herman, K. W. Schleifer et al., “CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function,” Journal of Experimental Medicine, vol. 202, no. 11, pp. 1549–1561, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. U. Dittmer, H. He, R. J. Messer et al., “Functional impairment of CD8+ T cells by regulatory T cells during persistent retroviral infection,” Immunity, vol. 20, no. 3, pp. 293–303, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Iwashiro, R. J. Messer, K. E. Peterson, I. M. Stromnes, T. Sugie, and K. J. Hasenkrug, “Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 16, pp. 9226–9230, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. E. M. Shevach, R. A. DiPaolo, J. Andersson, D. M. Zhao, G. L. Stephens, and A. M. Thornton, “The lifestyle of naturally occurring CD4+CD25+ Foxp3+ regulatory T cells,” Immunological Reviews, vol. 212, pp. 60–73, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  70. B. Salomon, D. J. Lenschow, L. Rhee et al., “B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes,” Immunity, vol. 12, no. 4, pp. 431–440, 2000. View at Google Scholar · View at Scopus
  71. Q. Tang, K. J. Henriksen, E. K. Boden et al., “Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells,” Journal of Immunology, vol. 171, no. 7, pp. 3348–3352, 2003. View at Google Scholar · View at Scopus
  72. A. E. Herman, G. J. Freeman, D. Mathis, and C. Benoist, “CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion,” Journal of Experimental Medicine, vol. 199, no. 11, pp. 1479–1489, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. Z. Chen, A. E. Herman, M. Matos, D. Mathis, and C. Benoist, “Where CD4+CD25+ T reg cells impinge on autoimmune diabetes,” Journal of Experimental Medicine, vol. 202, no. 10, pp. 1387–1397, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. C. Baecher-Allan and D. A. Hafler, “Human regulatory T cells and their role in autoimmune disease,” Immunological Reviews, vol. 212, pp. 203–216, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  75. D. Homann and M. Von Herrath, “Regulatory T cells and type 1 diabetes,” Clinical Immunology, vol. 112, no. 3, pp. 202–209, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. S. Gregori, N. Giarratana, S. Smiroldo, and L. Adorini, “Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development,” Journal of Immunology, vol. 171, no. 8, pp. 4040–4047, 2003. View at Google Scholar · View at Scopus
  77. S. You, M. Belghith, S. Cobbold et al., “Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells,” Diabetes, vol. 54, no. 5, pp. 1415–1422, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Brusko and M. Atkinson, “Treg in type 1 diabetes,” Cell Biochemistry and Biophysics, vol. 48, no. 2-3, pp. 165–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Lindley, C. M. Dayan, A. Bishop, B. O. Roep, M. Peatman, and T. I. M. Tree, “Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes,” Diabetes, vol. 54, no. 1, pp. 92–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. J. H. Buckner, “Mechanisms of impaired regulation by CD4++ CD25++ Foxp3++ regulatory T cells in human autoimmune diseases,” Nature Reviews Immunology, vol. 10, no. 12, pp. 849–859, 2010. View at Publisher · View at Google Scholar · View at PubMed
  81. Y. J. Liu, V. Soumelis, N. Watanabe et al., “TSLP: an epithelial cell cytokine that regulates t cell differentiation by conditioning dendritic cell maturation,” Annual Review of Immunology, vol. 25, pp. 193–219, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  82. N. Watanabe, YI. H. Wang, H. K. Lee et al., “Hassall's corpuscles instruct dendritic cells to induce CD4+ CD25+ regulatory T cells in human thymus,” Nature, vol. 436, no. 7054, pp. 1181–1185, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  83. J. Nerup, P. Platz, O. O. Andersen et al., “HLA antigens and diabetes mellitus,” The Lancet, vol. 2, pp. 864–866, 1974. View at Google Scholar
  84. J. A. Noble, A. M. Valdes, M. Cook, W. Klitz, G. Thomson, and H. A. Erlich, “The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families,” American Journal of Human Genetics, vol. 59, no. 5, pp. 1134–1148, 1996. View at Google Scholar · View at Scopus
  85. K. H. Lee, K. W. Wucherpfennig, and D. C. Wiley, “Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type I diabetes,” Nature Immunology, vol. 2, no. 6, pp. 501–507, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  86. S. Nejentsev, J. M. M. Howson, N. M. Walker et al., “Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A,” Nature, vol. 450, no. 7171, pp. 887–892, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  87. G. I. Bell, S. Horita, and J. H. Karam, “A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus,” Diabetes, vol. 33, no. 2, pp. 176–183, 1984. View at Google Scholar · View at Scopus
  88. S. T. Bennett, A. M. Lucassen, S. C. L. Gough et al., “Susceptibility to humantype 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulingene minisatellite locus,” Nature Genetics, vol. 9, pp. 284–292, 1995. View at Google Scholar
  89. L. Nisticò, R. Buzzetti, L. E. Pritchard et al., “The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes,” Human Molecular Genetics, vol. 5, no. 7, pp. 1075–1080, 1996. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Waterhouse, J. M. Penninger, E. Timms et al., “Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4,” Science, vol. 270, no. 5238, pp. 985–988, 1995. View at Google Scholar · View at Scopus
  91. N. Bottini, L. Musumeci, A. Alonso et al., “A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes,” Nature Genetics, vol. 36, no. 4, pp. 337–338, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  92. L. A. Criswell, K. A. Pfeiffer, R. F. Lum et al., “Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes,” American Journal of Human Genetics, vol. 76, no. 4, pp. 561–571, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  93. T. Vang, M. Congia, M. D. Macis et al., “Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant,” Nature Genetics, vol. 37, no. 12, pp. 1317–1319, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  94. M. Rieck, A. Arechiga, S. Onengut-Gumuscu, C. Greenbaum, P. Concannon, and J. H. Buckner, “Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes,” Journal of Immunology, vol. 179, no. 7, pp. 4704–4710, 2007. View at Google Scholar · View at Scopus
  95. P. R. Burton, D. G. Clayton, L. R. Cardon et al., “Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls,” Nature, vol. 447, no. 7145, pp. 661–678, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  96. H. Q. Qu, A. Montpetit, B. Ge, T. J. Hudson, and C. Polychronakos, “Toward further mapping of the association between the IL2RA locus and type 1 diabetes,” Diabetes, vol. 56, no. 4, pp. 1174–1176, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  97. J. A. McCann, Q. X. Yong, R. Frechette, L. Guazzarotti, and C. Polychronakos, “The insulin-like growth facfor-II receptor gene is associated with type 1 diabetes: evidence of a maternal effect,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5700–5706, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  98. R. Bailey, J. D. Cooper, L. Zeitels et al., “Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes,” Diabetes, vol. 56, no. 10, pp. 2616–2621, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  99. L. L. Field, V. Bonnevie-Nielsen, F. Pociot, S. Lu, T. B. Nielsen, and H. Beck-Nielsen, “OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes,” Diabetes, vol. 54, no. 5, pp. 1588–1591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  100. D. J. Smyth, J. D. Cooper, R. Bailey et al., “A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region,” Nature Genetics, vol. 38, no. 6, pp. 617–619, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  101. H. Kato, O. Takeuchi, S. Sato et al., “Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses,” Nature, vol. 441, no. 1, pp. 101–105, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus